New Delhi, Aug 12 () Glenmark Pharmaceuticals
today reported a 23.96 per cent rise in consolidated net profit to Rs
226.78 crore for the first quarter ended June 30, 2016, mainly on
account of robust sales.
The company had reported a net profit after tax, minority interest and share of profit of associates of Rs 182.94 crore for the corresponding period of the previous fiscal, Glenmark Pharmaceuticals said in a BSE filing.
Consolidated total income from operations of the company also rose to Rs 1,943.05 crore as against Rs 1,647.74 crore for the year-ago period.
Glenmark Pharmaceuticals Chairman and MD Glenn Saldanha said: "In the first quarter of this financial year, nearly all our businesses have rebounded strongly and we have seen good growth across all operating regions except Latam."
The US business continues to perform well and the recent approvals for the business will ensure that the growth momentum continues, he added.
About other markets, Saldanha said: "The Europe business performed well due to strong growth witnessed by the UK subsidiary. The ROW region also rebounded strongly due to a solid performance by the Russian business." Read more.......
The company had reported a net profit after tax, minority interest and share of profit of associates of Rs 182.94 crore for the corresponding period of the previous fiscal, Glenmark Pharmaceuticals said in a BSE filing.
Consolidated total income from operations of the company also rose to Rs 1,943.05 crore as against Rs 1,647.74 crore for the year-ago period.
Glenmark Pharmaceuticals Chairman and MD Glenn Saldanha said: "In the first quarter of this financial year, nearly all our businesses have rebounded strongly and we have seen good growth across all operating regions except Latam."
The US business continues to perform well and the recent approvals for the business will ensure that the growth momentum continues, he added.
About other markets, Saldanha said: "The Europe business performed well due to strong growth witnessed by the UK subsidiary. The ROW region also rebounded strongly due to a solid performance by the Russian business." Read more.......
No comments:
Post a Comment